Experimental study demonstrates Shiga toxin targets podocytes to trigger hemolytic uremic syndrome via endothelial complement activation, highlighting a novel mechanism for renal microvascular injury.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bowen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: